How many email patterns does Ovid Technologies use?

Ovid Technologies uses 4 known email patterns.

What domain does Ovid Technologies use for work emails?

Ovid Technologies uses ovid.com for work email addresses.

Most Common Email Formats at Ovid Technologies

Ovid Technologies's most common email format is FLast@ovid.com (ex. JDoe@ovid.com), used for 92% of ovid.com addresses. Ovid Technologies uses 4 email patterns.

@ovid.com

4 patterns

Format	Example	Share of ovid.com
FLast@ovid.comMost common	JDoe@ovid.com	92%
First_Last@ovid.com	John_Doe@ovid.com	4%
First.Last@ovid.com	John.Doe@ovid.com	3%
Last@ovid.com	Doe@ovid.com	1%

Need a specific person's email?

Browse Ovid Technologies's employee directory (about 93 employees) and reveal verified emails free.

Frequently Asked Questions

What does Ovid Technologies do?

Ovid Technologies operates in the Publishing industry, alongside similar companies like Thomson Reuters, American Chemical Society and Wiley-Blackwell. You can visit ovid.com or contact Ovid Technologies's headquarters by phone at

+1-801-304-****

. Explore Ovid Technologies's company overview page for more information.

What is Ovid Technologies's email address format?

Ovid Technologies's email format typically follows the pattern of FLast@ovid.com; this email format is used 92% of the time. Other contacts within LeadIQ's database had email formats such as First_Last@ovid.com and First.Last@ovid.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Ovid Technologies have currently?

Ovid Technologies has approximately 93 employees as of July 2026. Key team members to contact include Chief Executive Officer: J. T., Founder And Chief Executive Officer: J. K. and Owner: C. R. For more team information and contact data, explore Ovid Technologies's employee directory with LeadIQ.

Ovid Technologies Email Format

PublishingUnited States51-200 Employees

Ovid Technologies is a U.S.-based publisher operating in the book and periodical sector, with a focus on medical and scholarly content delivered through a research platform. The platform provides access to research articles, books, and media to support academic and clinical inquiry. In 2022, the platform expanded to include a Diversity, Equity and Inclusion collection. Additionally, the company has pursued licensing and collaboration opportunities, such as an option agreement with Healx for an exclusive license to gaboxadol (OV101) in 2022.

The company is part of the United States publishing landscape and concentrates on medical and scholarly content delivery. It has engaged in collaborations with pharmaceutical firms, including a past partnership with Takeda Pharmaceuticals tied to pediatric epilepsy drug trials.

Most common format

FLast@ovid.com

Example: JDoe@ovid.com

4 patterns. See all formats

Verify a Ovid Technologies email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Ovid Technologies

@ovid.com

Need a specific person's email?

Frequently Asked Questions

What does Ovid Technologies do?

What is Ovid Technologies's email address format?

How many employees does Ovid Technologies have currently?

Ovid Technologies Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.